Spinal muscular atrophy

Results: 193



#Item
21BEIKE BIOTECHNOLOGY Patient Case Study Spinal Muscular Atrophy Type 3 Female, 30 years old, March - April 2010 Background Age: 30 years old

BEIKE BIOTECHNOLOGY Patient Case Study Spinal Muscular Atrophy Type 3 Female, 30 years old, March - April 2010 Background Age: 30 years old

Add to Reading List

Source URL: beikebiotech.com

Language: English - Date: 2014-06-23 22:47:05
    22BEIKE BIOTECHNOLOGY Patient Case Study Spinal Muscular Atrophy Type 1 Male, 3 years old, May - June 2010 Background Age: 3 years old

    BEIKE BIOTECHNOLOGY Patient Case Study Spinal Muscular Atrophy Type 1 Male, 3 years old, May - June 2010 Background Age: 3 years old

    Add to Reading List

    Source URL: beikebiotech.com

    Language: English - Date: 2014-06-23 22:47:04
      23Dear Spinal Muscular Atrophy Community Members, We would like to update you on the clinical development of RG7800, an investigational SMN2 splicing modifier that is being studied as a potential treatment for spinal muscu

      Dear Spinal Muscular Atrophy Community Members, We would like to update you on the clinical development of RG7800, an investigational SMN2 splicing modifier that is being studied as a potential treatment for spinal muscu

      Add to Reading List

      Source URL: www.sma-schweiz.ch

      Language: English - Date: 2015-05-07 03:16:04
      24SMA Europe 7th Call for Research Projects

      SMA Europe 7th Call for Research Projects

      Add to Reading List

      Source URL: www.sma-europe.eu

      Language: English - Date: 2014-08-01 15:30:46
      25NUTRITION BASICS Fostering Health and Growth for Spinal Muscular Atrophy SMA Care Series  Contents

      NUTRITION BASICS Fostering Health and Growth for Spinal Muscular Atrophy SMA Care Series Contents

      Add to Reading List

      Source URL: www.fsma.org.hk

      Language: English - Date: 2013-04-29 02:31:34
      26Practice advisory on the treatment of amyotrophic lateral sclerosis with riluzole

      Practice advisory on the treatment of amyotrophic lateral sclerosis with riluzole

      Add to Reading List

      Source URL: www.promotingexcellence.org

      Language: English - Date: 2009-11-09 18:45:05
      27npg  Call in the backup The most common genetic killer of infants, a disease known as spinal muscular atrophy, is caused by mutations in a single gene. The human genome contains its own backup system—near-identical cop

      npg Call in the backup The most common genetic killer of infants, a disease known as spinal muscular atrophy, is caused by mutations in a single gene. The human genome contains its own backup system—near-identical cop

      Add to Reading List

      Source URL: www.fsma.org.hk

      Language: English - Date: 2013-04-29 02:31:53
      28ISIS INITIATES PHASE 1 CLINICAL STUDY OF ISIS-SMNRX IN PATIENTS WITH SPINAL MUSCULAR ATROPHY U.S. FDA has granted both Fast Track Status and Orphan Drug Designation for ISIS-SMNRx CARLSBAD, Calif., December 19, 2011 –

      ISIS INITIATES PHASE 1 CLINICAL STUDY OF ISIS-SMNRX IN PATIENTS WITH SPINAL MUSCULAR ATROPHY U.S. FDA has granted both Fast Track Status and Orphan Drug Designation for ISIS-SMNRx CARLSBAD, Calif., December 19, 2011 –

      Add to Reading List

      Source URL: www.fsma.org.hk

      Language: English - Date: 2013-04-29 02:31:35
      29Happy couple enjoying the surrounding

      Happy couple enjoying the surrounding

      Add to Reading List

      Source URL: www.vcgs.org.au

      Language: English - Date: 2013-04-28 20:01:23
      30AMYOTROPHIC LATERAL SCLEROSIS (ALS) (also known as Lou Gehrig’s Disease) DISEASE FACT SHEET AND OPPORTUNITY FOR TIRASEMTIV What is ALS? About Us Cytokinetics is a clinical-stage biopharmaceutical company

      AMYOTROPHIC LATERAL SCLEROSIS (ALS) (also known as Lou Gehrig’s Disease) DISEASE FACT SHEET AND OPPORTUNITY FOR TIRASEMTIV What is ALS? About Us Cytokinetics is a clinical-stage biopharmaceutical company

      Add to Reading List

      Source URL: www.cytokinetics.com

      Language: English - Date: 2015-02-24 12:44:30